Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor

Pathobiology

Volumn 81, Issue 3, 2014, Pages 138-148

  Oo, Htoo Zarni ^a   Sentani, Kazuhiro ^a   Sakamoto, Naoya ^a   Anami, Katsuhiro ^a   Naito, Yutaka ^a   Oshima, Takashi ^b   Yanagihara, Kazuyoshi ^c   Oue, Naohide ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

CAST; Gastric cancer; Scirrhous type gastric cancer; TM9SF3; Transmembrane 9 superfamily member 3

Indexed keywords

MEMBRANE PROTEIN; SMALL INTERFERING RNA; MESSENGER RNA; AMPICILLIN; SIGNAL PEPTIDE; TM9SF3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER TISSUE; CONTROLLED STUDY; ESCHERICHIA COLI AMPICILLIN SECRETION TRAP METHOD; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TM9SF3 GENE; TUMOR INVASION; AGED; ANALYTIC METHOD; CANCER STAGING; CANCER SURVIVAL; CELL GROWTH; CELL INVASION; ESCHERICHIA COLI; MTT ASSAY; SCIRRHOUS TYPE GASTRIC CANCER; TISSUE DISTRIBUTION; WESTERN BLOTTING; ADENOCARCINOMA, SCIRRHOUS; CELL MOTION; COMPARATIVE STUDY; DNA SEQUENCE; DRUG EFFECTS; EVALUATION STUDY; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; STOMACH NEOPLASMS; TUMOR CELL LINE;

ESCHERICHIA COLI;

ADENOCARCINOMA, SCIRRHOUS; AGED; AMPICILLIN; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; PROGNOSIS; PROTEIN SORTING SIGNALS; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 84895931502     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000357821     Document Type: Article

References (42)

1. Yasui W, Oue N, Kitadai Y, Nakayama H: Recent advances in molecular pathobiology of gastric carcinoma; in Kaminishi M, Takubo K, Mafune K (eds): The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis and Therapy. Tokyo, Springer, 2005, pp 51-71.
2. Lauren P: The two histologcal main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
3. Nakamura K, Sugano H, Takagi K: Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 1968; 59: 251-258.
4. Liu Y, Yoshimura K, Yamaguchi N, Shinmura K, Yokota J, Katai H: Causation of Borrmann type 4 gastric cancer: heritable factors or environmental factors? Gastric Cancer 2003; 6: 17-23.
5. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Ochiya T, Ino Y, Hirohashi S: Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 2005; 96: 323-332.
6. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996; 14: 1675-1680.
7. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 1995; 270: 484-487.
8. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H, Yasui W: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004; 64: 2397-2405.
9. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W: Expression and localization of Reg IV in human neoplastic and nonneoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005; 207: 185-198.
10. Sentani K, Oue N, Tashiro T, Sakamoto N, Nishisaka T, Fukuhara T, Taniyama K, Matsuura H, Arihiro K, Ochiai A, Yasui W: Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am J Surg Pathol 2008; 32: 1182-1189.
11. Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, Anami K, Motoshita J, Ito M, Tanaka S, Yoshida K, Yasui W: Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009; 125: 2383-2392.
12. Sentani K, Oue N, Sakamoto N, Arihiro K, Aoyagi K, Sasaki H, Yasui W: Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach. Mod Pathol 2008; 21: 464-475.
13. Sentani K, Oue N, Sakamoto N, Anami K, Naito Y, Aoyagi K, Sasaki H, Yasui W: Upregulation of connexin 30 in intestinal phenotype gastric cancer and its reduction during tumor progression. Pathobiology 2010; 77: 241-248.
14. Moon JH, Fujiwara Y, Nakamura Y, Okada K, Hanada H, Sakakura C, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y: REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma. J Surg Oncol 2012; 105: 189-194.
15. Anami K, Oue N, Noguchi T, Sakamoto N, Sentani K, Hayashi T, Hinoi T, Okajima M, Graff JM, Yasui W: Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype. J Pathol 2010; 221: 275-284.
16. Pruvot B, Laurens V, Salvadori F, Solary E, Pichon L, Chluba J: Comparative analysis of nonaspanin protein sequences and expression studies in zebrafish. Immunogenetics 2010; 62: 681-699.
17. Chang H, Jeung HC, Jung JJ, Kim TS, Rha SY, Chung HC: Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells. Breast Cancer Res Treat 2011; 125: 55-63.
18. Ferguson DA, Muenster MR, Zang Q, Spencer JA, Schageman JJ, Lian Y, Garner HR, Gaynor RB, Huff JW, Pertsemlidis A, Ashfaq R, Schorge J, Becerra C, Williams NS, Graff JM: Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trap. Cancer Res 2005; 65: 8209-8217.
19. Kadonaga JT, Gautier AE, Straus DR, Charles AD, Edge MD, Knowles JR: The role of the beta-lactamase signal sequence in the secretion of proteins by Escherichia coli. J Biol Chem 1984; 259: 2149-2154.
20. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112.
21. Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, Nakayama H, Yasui W: Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004; 64: 523-529.
22. Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, Ito H, Tahara E: Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 1993; 53: 36-41.
23. Ochiai A, Yasui W, Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 1985; 76: 1064-1071.
24. Motoyama T, Hojo H, Watanabe H: Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986; 36: 65-83.
25. Sekiguchi M, Sakakibara K, Fujii G: Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 1978; 48: 61-68.
26. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991; 51: 381-386.
27. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
28. Verjans E, Noetzel E, Bektas N, Schutz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J: Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer 2009; 9: 230.
29. Holness CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81: 1607-1613.
30. Hack AA, Groh ME, McNally EM: Sarcoglycans in muscular dystrophy. Microsc Res Tech 2000; 48: 167-180.
31. Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W: Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001; 115: 828-834.
32. Saitoh T, Katoh M: FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer. Int J Oncol 2001; 19: 311-315.
33. Cornillon S, Pech E, Benghezal M, Ravanel K, Gaynor E, Letourneur F, Bruckert F, Cosson P: Phg1p is a nine-transmembrane protein superfamily member involved in dictyostelium adhesion and phagocytosis. J Biol Chem 2000; 275: 34287-34292.
34. He P, Peng Z, Luo Y, Wang L, Yu P, Deng W, An Y, Shi T, Ma D: High-throughput functional screening for autophagy-related genes and identification of TM9SF1 as an autophagosome-inducing gene. Autophagy 2009; 5: 52-60.
35. Lozupone F, Perdicchio M, Brambilla D, Borghi M, Meschini S, Barca S, Marino ML, Logozzi M, Federici C, Iessi E, de Milito A, Fais S: The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep 2009; 10: 1348-1354.
36. Sugasawa T, Lenzen G, Simon S, Hidaka J, Cahen A, Guillaume JL, Camoin L, Strosberg AD, Nahmias C: The iodocyanopindolol and SM-11044 binding protein belongs to the TM9SF multispanning membrane protein superfamily. Gene 2001; 273: 227-237.
37. Schimmoller F, Diaz E, Muhlbauer B, Pfeffer SR: Characterization of a 76 kDa endosomal, multispanning membrane protein that is highly conserved throughout evolution. Gene 1998; 216: 311-318.
38. Yashiro M, Chung YS, Sowa M: Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer. Anticancer Res 1997; 17: 895-900.
39. Nakazawa K, Yashiro M, Hirakawa K: Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 2003; 63: 8848-8852.
40. Tahara E: Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron 2008; 1: 85-91.
41. Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001; 264: 169-184.
42. Sentani K, Matsuda M, Oue N, Uraoka N, Naito Y, Sakamoto N, Yasui W: Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma. Gastric Cancer DOI: 10.1007/s10120-013-0302-6.